期刊文献+

雌孕激素对卵巢癌细胞VEGF mRNA表达的影响 被引量:7

Effect of estrogen and progesterone on the expression of VEGF mRNA in epithelial ovarian cancer cell line
原文传递
导出
摘要 目的 探讨 17β 雌二醇 (17β E2 )或醋酸甲羟孕酮 (MPA)对卵巢癌细胞株血管内皮细胞生长因子 (VEGF)mRNA表达的影响。方法 采用 10 -12 ,10 -11,10 -10 ,10 -9,10 -8mol/L 17β -E2 或10 -9,10 -8,10 -7,10 -6,10 -5mol/LMPA作用于卵巢癌细胞株SKOV3细胞后 ,用半定量逆转录聚合酶链反应 (RT PCR)检测SKOV3细胞VEGFmRNA水平的变化。结果 VEGF的PCR产物均以 6 0 6bp和4 74bp为主。随着 10 -12 ~ 10 -8mol/L 17β E2 浓度的增加 ,SKOV3细胞VEGFmRNA的表达呈递增趋势 ;10 -11,10 -10 ,10 -9,10 -8mol/L 17β E2 组与对照组比较 ,差异有显著性 (P <0 .0 5 )。随着 10 -9~ 10 -5mol/LMPA浓度的增加 ,SKOV3细胞VEGFmRNA的表达呈下降趋势 ,且 6 0 6bp的变化比 4 74bp明显 ,6 0 6bp可能对MPA更为敏感 ,MPA各组与对照组比较 ,差异有显著性 (P <0 .0 5 ) ;除 10 -8,10 -7mol/LMPA组间比较外 ,其余各实验组间比较 ,差异有显著性 (P <0 .0 5 )。结论 雌激素可上调SKOV3细胞的VEGFmRNA水平的表达 ;孕激素可下调SKOV3细胞VEGFmRNA水平的表达。 Objective To study the effect of 17β-estradiol (17β-E 2) and medroxyprogesterone acetate (MPA) on the expression of VEGF mRNA in epithelial ovarian carcinoma cell line in vitro. Methods Human epithelial ovarian carcinoma cell line SKOV3 cells were exposed to 17β-E 2 (10 -12~10 -8 mol/L) or MPA(10 -9~10 -5 mol/L), the expression level of VEGF mRNA was determined by RT-PCR. Results The PCR products of VEGF were mainly 606 bp and 474 bp. The expression of VEGF mRNA in the 17β-E 2-treated cells was significantly higher than in the untreated control (P<0.05), the expression level of VEGF mRNA increased with the increase in 17β-E 2 concentration. The expression of VEGF mRNA in SKOV3 cells treated with MPA (10 -9~10 -5mol/L) was significantly lower than in the untreated control (P<0.05), especially that of 606 bp. Conclusion Estrogen can up-regulate, while progesterone can down-regulate mRNA expression of VEGF. Further studies are needed to elucidate the mechanism.
作者 李华 孙红
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2004年第5期264-267,共4页 Chinese Journal of Oncology
关键词 雌孕激素 卵巢癌 癌细胞 VEGFMRNA表达 肿瘤 血管内皮细胞生长因子 信使核糖核酸 Ovarian neoplasms Estrogen Progesterone VEGF mRNA
  • 相关文献

参考文献10

  • 1OkadaY ,,TsuchiyaH,ShimizuH ,etal.Inductionandstimulationof92000gelatinase/typeⅣcollagenaseproductioninosteosarcomaandfibrosarcomacelllinesbytumornecrosisfactoralpha[].Biochemical and Biophysical Research Communications.1990
  • 2Fujimoto J,Sakaguchi H,Hirose R,et al.Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells[].Cancer Letters.1999
  • 3STONER M,WANG F,WORMKE M,et al.Inhibition of vascular endothelial growth factor expression in HEC1A endometrial cancer cells through interactions of estrogen receptor alpha and Sp3 proteins[].Journal of Biological Chemistry.2000
  • 4Hyder SM,Huang JC,Nawaz Z,et al.Regulation of vascular endothelial growth factor expression by estrogens and progestins[].Environmental Health Perspectives.2000
  • 5Kraft A,Weindel K,Ochs A,et al.Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease[].Cancer.1999
  • 6Chen CA,Cheng WF,Lee CN,et al.Serum vascular endothelial growth factor in epthelial ovarian neoplasms: correlation with patient survival[].Gynecologic Oncology.1999
  • 7Olson TA,Mohanraj D,Carson LF,et al.Vascular permeability factor gene expression in normal and neoplastic human ovaries[].Cancer Research.1994
  • 8Thomas K A.Vascular endothelial growth factor,a potent and selective angiogenic agent[].Journal of Biological Chemistry.1996
  • 9Fujimoto J,Sakaguchi H,Hirose R,et al.Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma[].Cancer.1998
  • 10Millauer B,Shawver LK,Plate KH,et al.Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant[].Nature.1994

同被引文献66

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部